該雜志國際簡稱:CANCER RES TREAT,是由出版商Korean Cancer Association出版的一本致力于發(fā)布醫(yī)學研究新成果的的專業(yè)學術期刊。該雜志以ONCOLOGY研究為重點,主要發(fā)表刊登有創(chuàng)見的學術論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術影響力。
《Cancer Research And Treatment》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱癌癥研究與治療,本刊主要出版、報道醫(yī)學-ONCOLOGY領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果,介紹該領域有關本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術信息交流,提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄,為該領域相關學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為4.1,最新CiteScore 指數(shù)為8。
本刊近期中國學者發(fā)表的論文主要有:
The Lymphatic Drainage Pattern of Internal Mammary Sentinel Lymph Node Identified by Small Particle Radiotracer (99mTc-Dextran 40) in Breast.
Author: Cao XS1,2, Yang GR2,3, Cong BB1,2,4, Qiu PF1,2, Wang YS1,2.
A Comprehensive Assessment of the Racial and Ethnic Disparities in the Incidence of Gastric Cancer in the United States, 1992-2014.
Author: Yao Q1,2, Qi X3, Cheng W1, Xie SH4.
Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer.
Author: Baglia ML1, Cui Y1, Zheng T2, Yang G1, Li H3, You M1, Xu L2, Murff H4, Gao YT3, Zheng W1, Xiang YB3, Shu XO1.
Upregulation of PITX2 Promotes Letrozole Resistance Via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells.
Author: Xu YY1, Yu HR2, Sun JY2, Zhao Z3, Li S3, Zhang XF3, Liao ZX3, Cui MK3, Li J3, Li C3, Zhang Q3.
英文介紹
Cancer Research And Treatment雜志英文介紹
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.